The Multiple Sclerosis Impact Scale (MSIS-29) mean score presented as... | Download Scientific Diagram
Databases Using them to study MS in the UK. Proposed research using: GPRD (General Practice Research Database) MSNTC Northwood Database. - ppt download
Multiple Sclerosis (MS) Case Study - Physiopedia
Multiple Sclerosis Impact Scale (MSIS-29) - YouTube
PDF) Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS-29) | Geir Resaland - Academia.edu
Correlation of change in the Multiple Sclerosis Impact Scale (MSIS)-29... | Download Scientific Diagram
Patient-reported Outcome Measures in Multiple Sclerosis. | Semantic Scholar
Cells | Free Full-Text | Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT) - Sophie Cleanthous, Stefan Cano, Elizabeth Kinter, Patrick Marquis, Jennifer
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale–Eight Dimensions–Patient Version (MSIS-8D-P) - ScienceDirect
The Multiple Sclerosis Impact Scale (MSIS-29) (Chapter 3) - Quality of Life Measurement in Neurodegenerative and Related Conditions
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies - Antoine Regnault, Angely Loubert, Róisín Brennan,
The perceived impact of multiple sclerosis and self-management: The mediating role of coping strategies | PLOS ONE
Heatmap of the responses to Multiple Sclerosis Impact Scale-29... | Download Scientific Diagram
A Quality-Adjusted Life-Year Measure for Multiple Sclerosis: Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure - ScienceDirect
PDF) Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient's Perspective | Miguel Hernández-Pérez - Academia.edu
Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies - Antoine Regnault, Angely Loubert, Róisín Brennan,
Brain Sciences | Free Full-Text | Cognitive Fatigue in Multiple Sclerosis: An Objective Approach to Diagnosis and Treatment by Transcranial Electrical Stimulation
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis | PharmacoEconomics
Table 2 from Italian Validation of the 12-Item Multiple Sclerosis Walking Scale | Semantic Scholar
Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT) - Sophie Cleanthous, Stefan Cano, Elizabeth Kinter, Patrick Marquis, Jennifer
